Kimberly-Clark Capitalized research costs decreased by 25.0% to $204.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 25.0%, from $272.00M to $204.00M.
An increase suggests higher investment in long-term R&D projects that are being amortized over time, while a decrease may indicate a shift toward immediate expensing or completion of projects.
This represents the portion of research and development expenditures that have been capitalized as an asset rather than...
Common in consumer goods firms with significant innovation pipelines; peers often report this as part of deferred tax asset schedules.
other_deferred_tax_assets_capitalized_research_costs| Q4 '21 | Q4 '22 | Q4 '23 | Q4 '24 | Q4 '25 | |
|---|---|---|---|---|---|
| Value | $0.00 | $118.00M | $224.00M | $272.00M | $204.00M |
| QoQ Change | — | — | +89.8% | +21.4% | -25.0% |
| YoY Change | — | — | +89.8% | +21.4% | -25.0% |